Healthcare ETFs: I Prefer VHT's Growth To XLV's Stability

After some difficult years of low returns, and especially the last three ones that saw a lot of volatility, the US healthcare industry is seeing new tailwinds through innovations (think GLP-1 agonists and gene therapies), making the sectorI am a dynamic finance professional with a Master’s in Banking & Finance from Université Paris 1 Panthéon-Sorbonne. My investing background mix corporate finance, M&A, and investment analysis, with a focus on real estate, renewable energy, and equity markets. I specialize ...